- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
UCSF experts warn against cholesterol quick fix with statins
By UCSF School of Pharmacy Editorial Staff / Wed Mar 16, 2005
Steve Kayser, PharmD, clinical pharmacist and cardiology drug expert warns that the risks could outweigh the benefits of making cholesterol-lowering drugs, called statins, available in the United States without a prescription. In January 2005, two United States Food and Drug Administration expert committees voted down such a proposal for American consumers, citing concerns for patient safety. Statins are now available over the counter in the United Kingdom. • Full story: Panorama: Upending the Statin Quo.
Tags
Keywords:
Category:
Sites:
School of Pharmacy, Department of Clinical Pharmacy, PharmD Degree Program
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
Related news
- Know your cholesterol numbers when considering a drug
- Students study global pharmacy practices
- Analysis finds sponsorship biases in animal studies may differ from those in clinical trials
- Oni-Orisan given the Darrell Abernethy Early Stage Investigator Award
- Burchard named to expert panel for Obama’s precision medicine plan
